Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion type Assertion NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_head.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion description "[Indeed, sustained treatment with the Odc suicide inhibitor alpha-difluoromethylornithine (DFMO) or Odc heterozygosity markedly impairs lymphoma development in Emicro-Myc transgenic mice, and these effects are linked to the induction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1), which is normally repressed by Myc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_provenance.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion evidence source_evidence_literature NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_provenance.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion SIO_000772 19147568 NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_provenance.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion wasDerivedFrom befree-20150227 NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_provenance.
- NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_assertion wasGeneratedBy ECO_0000203 NP303274.RAbmlCRfq6mRntkIb0fEaS4OvIEPchB4V_UJsA0WyWCuI130_provenance.